PL2956150T3 - Frakcja surowicy z fibryny bogatopłytkowej - Google Patents

Frakcja surowicy z fibryny bogatopłytkowej

Info

Publication number
PL2956150T3
PL2956150T3 PL14707886T PL14707886T PL2956150T3 PL 2956150 T3 PL2956150 T3 PL 2956150T3 PL 14707886 T PL14707886 T PL 14707886T PL 14707886 T PL14707886 T PL 14707886T PL 2956150 T3 PL2956150 T3 PL 2956150T3
Authority
PL
Poland
Prior art keywords
platelet
serum fraction
rich fibrin
fibrin
rich
Prior art date
Application number
PL14707886T
Other languages
English (en)
Inventor
Zsombor Lacza
Gabriella Vacz
Original Assignee
Lacerta Technologies Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacerta Technologies Inc. filed Critical Lacerta Technologies Inc.
Publication of PL2956150T3 publication Critical patent/PL2956150T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL14707886T 2013-02-12 2014-02-12 Frakcja surowicy z fibryny bogatopłytkowej PL2956150T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361763504P 2013-02-12 2013-02-12
EP14707886.9A EP2956150B1 (en) 2013-02-12 2014-02-12 Serum fraction of platelet-rich fibrin
PCT/US2014/015962 WO2014126970A1 (en) 2013-02-12 2014-02-12 Serum fraction of platelet-rich fibrin

Publications (1)

Publication Number Publication Date
PL2956150T3 true PL2956150T3 (pl) 2022-01-03

Family

ID=50193598

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14707886T PL2956150T3 (pl) 2013-02-12 2014-02-12 Frakcja surowicy z fibryny bogatopłytkowej

Country Status (13)

Country Link
US (2) US9480716B2 (pl)
EP (1) EP2956150B1 (pl)
AU (1) AU2014216415B2 (pl)
CA (1) CA2900971C (pl)
DK (1) DK2956150T3 (pl)
ES (1) ES2896338T3 (pl)
HU (1) HUE056391T2 (pl)
IL (1) IL240437B (pl)
PL (1) PL2956150T3 (pl)
RU (1) RU2711330C2 (pl)
SG (1) SG11201506259WA (pl)
SI (1) SI2956150T1 (pl)
WO (1) WO2014126970A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017152172A1 (en) * 2016-03-04 2017-09-08 Lacerta Technologies Inc. Chondrocyte proliferation
JP6649257B2 (ja) * 2013-08-27 2020-02-19 クック・ジェネラル・バイオテクノロジー・エルエルシー 濃厚血小板から誘導可能な生理活性組成物並びにその調製方法及び使用方法
ES2564580B1 (es) * 2014-09-22 2016-12-28 Biotechnology Institute, I Mas D, S.L. Método de preparación de una composición rica en plaquetas y/o factores de crecimiento
CN104337835B (zh) * 2014-11-13 2018-11-20 河南金泰生物技术股份有限公司 一种富血小板血浆的制备方法
EP3092987A1 (de) * 2015-05-11 2016-11-16 3M Innovative Properties Company System zur wundbehandlung mit serum
US20180353118A1 (en) 2015-12-03 2018-12-13 Lacerta Technologies Inc. Method and Apparatus For Preparing Blood Fraction Concentrate
EP3452500A4 (en) * 2016-05-06 2019-12-11 Lacerta Technologies Inc. PROLIFERATION OF MESENCHYMAL STEM CELLS
EP3624830A4 (en) * 2017-05-15 2020-12-30 Miron, Richard J. LIQUID LABEL-RICH FIBRIN AS A CARRIER SYSTEM FOR BIOMATERIALS AND BIOMOLECULES
TW201936627A (zh) * 2018-02-26 2019-09-16 鄭本岡 具有高活化細胞因子的血清之備製方法
WO2020163787A1 (en) * 2019-02-07 2020-08-13 Biobridge Global Methods and compositions related to platelet releasate and platelet-rich fibrin
TR201908181A2 (tr) * 2019-05-29 2020-12-21 Univ Istanbul Rektoerluegue Trombosi̇t konsantresi̇ i̇le vi̇tami̇n/mi̇neral i̇laç/hormon/enzi̇m/bi̇yomateryal bi̇leşi̇mi̇ni̇n eldesi̇
WO2021206669A1 (en) * 2020-04-06 2021-10-14 Reosteon, Llc Method and apparatus for ensuring maintenance and integrity of surgical implant survival in human and veterinary patients
RU2761726C1 (ru) * 2021-06-01 2021-12-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный медицинский университет им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Способ лечения пациентов с одонтогенным остеомиелитом
CN115463249A (zh) * 2022-08-11 2022-12-13 中南大学湘雅医院 一种负载富血小板血浆水凝胶及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062828A1 (en) 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
DE102006005016A1 (de) 2006-02-03 2007-08-16 Orthogen Ag Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung
WO2007127841A2 (en) 2006-04-26 2007-11-08 Arteriocyte Medical Systems, Inc. Compositions and methods of preparation thereof
WO2010020247A1 (en) 2008-08-22 2010-02-25 Reapplix Aps Multilayered blood product
EP2393501A1 (en) 2009-02-05 2011-12-14 Pierre Philippart Method and means for producing tissues and tissues obtained
WO2013116791A1 (en) * 2012-02-02 2013-08-08 Mosaic Biosciences, Inc. Biomaterials for delivery of blood extracts and methods of using same

Also Published As

Publication number Publication date
SI2956150T1 (sl) 2022-02-28
ES2896338T3 (es) 2022-02-24
IL240437B (en) 2019-06-30
CA2900971C (en) 2023-08-08
EP2956150A1 (en) 2015-12-23
IL240437A0 (en) 2015-09-24
CA2900971A1 (en) 2014-08-21
AU2014216415B2 (en) 2016-12-15
US10111906B2 (en) 2018-10-30
SG11201506259WA (en) 2015-09-29
US20140227241A1 (en) 2014-08-14
RU2015137965A3 (pl) 2018-02-28
AU2014216415A1 (en) 2015-09-24
RU2711330C2 (ru) 2020-01-16
US20170035809A1 (en) 2017-02-09
WO2014126970A1 (en) 2014-08-21
DK2956150T3 (da) 2021-11-01
US9480716B2 (en) 2016-11-01
HUE056391T2 (hu) 2022-02-28
EP2956150B1 (en) 2021-08-11
RU2015137965A (ru) 2017-03-20

Similar Documents

Publication Publication Date Title
IL275497A (en) Serum proteins with type III fibronectin binding domains
IL281703A (en) New heterodimeric proteins
IL284301A (en) Heterodimeric proteins
IL240437A0 (en) A fraction of fibrin serum is rich in platelets
HK1223402A1 (zh) 免疫溶瘤療法
HK1217499A1 (zh) 蛋白的多聚形式
HK1213019A1 (zh) 改良的測定方法
GB201309652D0 (en) Aa centrifuge
HK1214252A1 (zh) 作為凝血酶抑制劑的鹵代吡唑
GB201308057D0 (en) Protein
GB201401955D0 (en) Protein
GB201302031D0 (en) Protein
GB201302030D0 (en) Protein